Loading…
← CockpitCompetitor Analysis › RHK.DE Rhon-klinikum AGOpen in the cockpit ↗

Rhon-klinikum AGRHK.DECompetitor analysis, valuation and peers

Germany · EUR·Health Care›Hospital/Nursing Management

German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.

≈ A German HCA Healthcare, smaller scaleMomentum strong 69
Mkt cap
$1.06B
US dollars, full cap
Free float
5%
of shares outstanding
$/day
$9,877
20-day average traded
Fwd P/E
22.5×
forward earnings
ROIC−WACC
-51.5 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
134 days
1 Apr 2027
Close · EUR€14.40
1D-2.0%
1W-1.4%
1M-2.7%
3M-2.0%
6M+15.2%
YTD+13.4%
1Y+20.0%
ATR %2.2%
52w lowhigh8.3% off high

What Rhon-klinikum does

German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.

Paid per patient case under Germany's flat-rate system, set by insurers and state hospital planning, so margins depend on keeping costs under the fixed fees and filling beds. Governments pay for buildings and equipment; insurers pay running costs. The university hospital in Giessen and Marburg is a major site.

In one line: A German HCA Healthcare, smaller scale.

Products and services

  • Acute-care hospitals
  • University/teaching hospital partnerships
  • Specialty medical centers

Customers

  • Patients (statutory/private insured)
  • German public health insurers

Where it sits in the supply chain

  • Health Care
  • Hospital services
  • Private acute-care hospital operator

What could go right

  • Aging population inpatient demand
  • Hospital consolidation efficiencies

What could go wrong

  • German DRG tariff pressure/hospital reform
  • Staff shortages/wage inflation

Moat: narrow (regulatory licence, scale, installed base). Licensed hospital capacity and academic-medicine partnerships, but reimbursement rates are government-regulated.

Headquarters: Bad Neustadt an der Saale, Germany · Founded: 1973 · Employees: 19,128

Named competitors

Rhon-klinikum at a glance

Size Rhon-klinikum (RHK.DE) is a Germany Health Care company (Hospital/Nursing Management) with a market value of $1.06B, the 138th largest of 198 Germany companies the cockpit tracks. Shares closed at €14.40 on 18 Nov 2026.

Performance Over six months the shares gained 15.2%, against -3.8% for the median peer and -0.9% for the Germany market (cap-weighted) — 5th highest of 20 in its peer set.

Growth Revenue grew 3.5% over the last twelve months (peer median +14.8%); the operating margin is -51.3% (peer median 10.8%).

Valuation It trades at 22.5× forward earnings against a peer median of 40.4× (4th cheapest of 16).

Capital Return on invested capital runs 51.5 points below its cost of capital (5.0% WACC).

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

9010011012021 May 202621 Aug 202618 Nov 2026RHK.DE 113Peer median 94
Six months, rebased to 100: Rhon-klinikum against the median of its 20 peers (local-currency closes).

Rhon-klinikum financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€1.75B€1.94B€1.83B€1.67B€1.63B
Revenue growth—+6%+9%+2%—
Gross profitn/a€168M€171M€136M€160M
EBITDAn/a€69.4M€69.0M€45.7M€88.3M
Net income€42.4M€34.5M€43.4M€38.7M€25.1M
Free cash flown/a-€34.6M€68.3M€56.7M-€15.7M
Capital expendituren/a€99.1M€70.4M€62.8M€58.2M
Total debtn/a€122M€150M€150M€158M

Quarterly statements and history in the cockpit →

Rhon-klinikum competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%+20%PARKHOSPSJLHLCBAVYATHARTHGDSHCGA50CVSGBSLSPI301293RAINBOWAEVSKOVAIEXEARTEMISMEDRHK.DE6-month return →1-month return →
Up and to the right = strong over both horizons. Rhon-klinikum is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%50×100×PARKHOSPSJLHLCBAVYATHARTHHCGCVSGBSL301293RAINBOWAEVSSIAEXEARTEMISMEDRHK.DERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Rhon-klinikum is the large dot.

Rhon-klinikum competitors and peer comparison

Head to head with its named competitors (RHK.DE vs FRE.DE)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Rhon-klinikum RHK.DE$1.06B+15%+4%-51%22.5×n/a
Fresenius SE & Co. KGaA FRE.DE$32.7B+41%+7%10%14.7×7.0%

How Rhon-klinikum compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Rhon-klinikum against its 20 peers (data as of 18 Nov 2026)
MeasureRHK.DEPeer medianRank in peer set
1-month return-2.7%+1.8%3rd lowest of 20
6-month return+15.2%-3.8%5th highest of 20
Distance from 52-week high-8.3%-18.4%5th highest of 21
Revenue growth (TTM)+3.5%+14.8%6th lowest of 21
Operating margin-51.3%10.8%lowest of 21
Forward P/E22.5×40.4×4th cheapest of 16
ROIC minus cost of capital-51.5 pp-2.2 pplowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Yatharth Hospital and Trauma Care Services YATHARTH.NSIndia$1.13B+31%+50%16%49.4×n/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
CVS CVSG.LUnited Kingdom$1.22B+17%+6%11%14.6×14.2%+6.9%
Raffles Medical BSL.SISingapore$1.23B-13%-3%11%27.1×-2.7%+6.1%
Spire Healthcare SPI.LUnited Kingdom$1.31B+11%+2%8%25.1×10.0%+11.4%
Sanbo Hospital Management 301293.SZChina$1.35B-29%+17%6%135.5×n/an/a
Rainbow Childrens Medicare RAINBOW.NSIndia$1.37B-7%+23%22%40.4×30.7%+21.2%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%106.8×26.5%+10.2%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%n/a12.7%+20.6%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%40.9×18.9%+8.6%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%23.5×2.1%+10.4%
Extendicare EXE.TOCanada$1.91B-16%+36%9%19.3×10.8%+8.5%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%

Questions

Who are Rhon-klinikum's main competitors?
Named competitors: Asklepios (private) (private or unlisted), Fresenius (Helios Kliniken) (FRE.DE), Sana Kliniken (private) (private or unlisted). The cockpit's measured peer set (industry) also includes Park Medi World (PARKHOSPS.NS), Jupiter Life Line Hospitals (JLHL.NS), Clinica Baviera (CBAV.MC), Yatharth Hospital and Trauma Care Services (YATHARTH.NS), Ramsay Generale de Sante (GDS.PA), Paras Healthcare (PARASHLTH.NS).
Is Rhon-klinikum expensive compared with its peers?
On forward p/e it trades at 22.5× against a peer median of 40.4×, 4th cheapest of 16 in its peer set.
How has Rhon-klinikum stock performed?
Over six months to 18 Nov 2026 the shares returned +15.2% against -3.8% for the median peer; over one year +20.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.